WhiteOak Capital Pharma and Healthcare Fund Regular Plan Growth
Category: Equity: Sectoral-Pharma and Healthcare |
Launch Date: 06-02-2024 |
Asset Class: |
Benchmark: BSE Healthcare TRI |
Expense Ratio: 2.39% As on (31-01-2025) |
Status: Open Ended Schemes |
Minimum Investment: 100.0 |
Minimum Topup: 100.0 |
Total Assets: 283 Cr As on (31-12-2024) |
Turn over: - |
12.104
0.04 (0.2892%)
19.09%
BSE Healthcare TRI 14.71%
PERFORMANCE of WhiteOak Capital Pharma and Healthcare Fund Regular Plan Growth
Scheme Performance (%)
Data as on - 25-02-2025Yearly Performance (%)
Fund Managers
Piyush Baranwal, Ramesh Mantri, Dheeresh Pathak
Investment Objective
The Scheme seeks to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies.
NAV & Lumpsum details( Invested amount 1,00,000)
NAV Date | NAV | Units | Market Value |
Returns (%) |
---|---|---|---|---|
07-02-2024 | 10.072 | 9928.5147 | 100000 | 0.0 % |
07-03-2024 | 9.944 | - | 98729 | -1.27 % |
08-04-2024 | 10.076 | - | 100040 | 0.04 % |
07-05-2024 | 10.02 | - | 99484 | -0.52 % |
07-06-2024 | 10.337 | - | 102631 | 2.63 % |
08-07-2024 | 10.889 | - | 108112 | 8.11 % |
07-08-2024 | 11.703 | - | 116193 | 16.19 % |
09-09-2024 | 12.724 | - | 126330 | 26.33 % |
07-10-2024 | 12.732 | - | 126410 | 26.41 % |
07-11-2024 | 13.183 | - | 130888 | 30.89 % |
09-12-2024 | 13.403 | - | 133072 | 33.07 % |
07-01-2025 | 13.876 | - | 137768 | 37.77 % |
07-02-2025 | 13.301 | - | 132059 | 32.06 % |
25-02-2025 | 12.104 | - | 120175 | 20.18 % |
RETURNS CALCULATOR for WhiteOak Capital Pharma and Healthcare Fund Regular Plan Growth
Growth of 10000 In SIP (Fund vs Benchmark)
Growth of 10000 In LUMPSUM (Fund vs Benchmark)
Rolling Returns
Rolling returns are the annualized returns of the scheme taken for a specified period (rolling returns period) on every day/week/month and taken till the last day of the duration. In this chart we are showing the annualized returns over the rolling returns period on every day from the start date and comparing it with the benchmark. Rolling returns is the best measure of a fund's performance. Trailing returns have a recency bias and point to point returns are specific to the period in consideration. Rolling returns, on the other hand, measures the fund's absolute and relative performance across all timescales, without bias.
Riskometer
Key Performance and Risk Statistics of WhiteOak Capital Pharma and Healthcare Fund Regular Plan Growth
Key Statistics | Volatility | Sharpe Ratio | Alpha | Beta | Yield to Maturity | Average Maturity |
---|---|---|---|---|---|---|
WhiteOak Capital Pharma and Healthcare Fund Regular Plan Growth | - | - | - | - | - | - |
Equity: Sectoral-Pharma and Healthcare | - | - | - | - | - | - |
PEER COMPARISION of WhiteOak Capital Pharma and Healthcare Fund Regular Plan Growth
PORTFOLIO ANALYSIS of WhiteOak Capital Pharma and Healthcare Fund Regular Plan Growth
Asset Allocation (%)
Allocation | Percentage (%) |
---|
Market Cap Distribution
Small Cap
36.33%
Others
7.71%
Large Cap
26.29%
Mid Cap
29.67%
Total
100%